SCHEMBL4869828

SCHEMBL4869828

CC(C)N(C(=O)CBr)c1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
LMNA P02545 2/20 0.51
TP53 P04637 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
GSK3B P49841 1/20 0.43
GPBAR1 Q8TDU6 2/20 0.40
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA4 P43681 1/20 0.39
MLYCD O95822 1/20 0.37
USP2 O75604 1/20 0.37
HTT P42858 2/20 0.37
RAB9A P51151 1/20 0.37
POLB P06746 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CYP3A4 P08684 1/20 0.36
MAPKAPK2 P49137 1/20 0.36
CNR2 P34972 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8705032 0.84 ALDH1A1 (0.49) ALDH1A1LMNATP53SMN1; SMN2MLYCD
SCHEMBL8426915 0.84 ALDH1A1 (0.49) ALDH1A1LMNATP53SMN1; SMN2GSK3B
SCHEMBL22311444 0.84 ALDH1A1 (0.72) ALDH1A1LMNATP53SMN1; SMN2GSK3B
SCHEMBL22289629 0.83 ALDH1A1 (0.51) ALDH1A1LMNATP53SMN1; SMN2GPBAR1
SCHEMBL5103764 0.83 ALDH1A1 (0.47) ALDH1A1LMNATP53SMN1; SMN2MLYCD
SCHEMBL5107126 0.82 ALDH1A1 (0.69) ALDH1A1LMNATP53SMN1; SMN2GSK3B
SCHEMBL11383766 0.81 LMNA (0.50) ALDH1A1LMNATP53SMN1; SMN2GPBAR1
SCHEMBL11384569 0.81 ALDH1A1 (0.40) ALDH1A1LMNATP53SMN1; SMN2GSK3B
SCHEMBL4869949 0.80 GSK3B (0.49) ALDH1A1LMNATP53SMN1; SMN2GSK3B
SCHEMBL8430703 0.79 MLYCD (0.49) ALDH1A1LMNATP53SMN1; SMN2GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442693-B2 Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors SMITHKLINE BEECHAM CORPORATION (US) 2008-10-28 US disclosed
US-20070270411-A1 Novel Diazepine Compounds as Ligands of the Melanocortin 1 and/or 4 Receptors SMITHKLINE BEECHAM CORPORATION 2007-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270411-A1 Novel Diazepine Compounds as Ligands of the Melanocortin 1 and/or 4 Receptors MC4R, MC3R, MC5R ALDH1A1 2986/4885LMNA 3785/4885TP53 4881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.